Publicaciones en colaboración con investigadores/as de Hospital Universitario de Cruces (28)

2024

  1. Galunisertib downregulates mutant type I collagen expression and promotes MSCs osteogenesis in pediatric osteogenesis imperfecta

    Biomedicine and Pharmacotherapy, Vol. 175

2022

  1. Analysis of standard concentrations of continuous infusions in nine Spanish neonatal intensive care units

    European Journal of Hospital Pharmacy, Vol. 29, Núm. 1, pp. 50-54

  2. Key Factors in Effective Patient-Tailored Dosing of Fluoroquinolones in Urological Infections: Interindividual Pharmacokinetic and Pharmacodynamic Variability

    Antibiotics, Vol. 11, Núm. 5

  3. Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study

    Journal of Intensive Care, Vol. 10, Núm. 1

2021

  1. Drug compatibility in neonatal intensive care units: gaps in knowledge and discordances

    European Journal of Pediatrics, Vol. 180, Núm. 7, pp. 2305-2313

  2. Intravenous drug use in neonatal intensive care units

    European Journal of Hospital Pharmacy, Vol. 28, Núm. 6, pp. 341-345

  3. Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units

    European Journal of Pediatrics, Vol. 180, Núm. 4, pp. 1169-1176

  4. Population pharmacokinetics of levetiracetam and dosing evaluation in critically ill patients with normal or augmented renal function

    Pharmaceutics, Vol. 13, Núm. 10

2019

  1. Fractures Related to Tenofovir: A Case/Noncase Study in the European Pharmacovigilance Database

    American journal of therapeutics, Vol. 26, Núm. 5, pp. e589-e592

2018

  1. Augmented Renal Clearance in Critically Ill Patients: A Systematic Review

    Clinical Pharmacokinetics, Vol. 57, Núm. 9, pp. 1107-1121

2017

  1. Development of a risk stratification model for pharmaceutical care in HIV patients

    Farmacia Hospitalaria, Vol. 41, Núm. 3, pp. 346-356

  2. Intravenous medicine preparation technique training programme for nurses in clinical areas

    European Journal of Hospital Pharmacy , Vol. 25, Núm. 6, pp. 298-300

  3. Sunitinib-induced hypertension in CYP3A4 rs4646437 A-allele carriers with metastatic renal cell carcinoma

    Pharmacogenomics Journal, Vol. 17, Núm. 1, pp. 42-46

2016

  1. Medicine preparation errors in ten Spanish neonatal intensive care units

    European Journal of Pediatrics, Vol. 175, Núm. 2, pp. 203-210

  2. Strategies implementation to reduce medicine preparation error rate in neonatal intensive care units

    European Journal of Pediatrics, Vol. 175, Núm. 6, pp. 755-765

2015

  1. Drug interactions with sunitinib

    Journal of Oncology Pharmacy Practice, Vol. 21, Núm. 1, pp. 52-66

  2. Medication errors in neonatal care: A systematic review of types of errors and effectiveness of preventive strategies

    Journal of Neonatal Nursing, Vol. 21, Núm. 5, pp. 200-208

2014

  1. Gemcitabine: Molecular pharmacology, pharmacogenetics and adverse reaction profile

    Gemcitabine: Pharmacology, Clinical Uses and Potential Side Effects (Nova Science Publishers, Inc.), pp. 1-62

2013

  1. Errores en la preparación de fármacos intravenosos en una Unidad de Cuidados Intensivos Neonatal. Una potencial fuente de eventos adversos

    Anales de Pediatria, Vol. 79, Núm. 1, pp. 21-25

  2. Tacrolimus dose individualization in "de novo" patients after 10 years of experience in liver transplantation: Pharmacokinetic considerations and patient pathophysiology

    International Journal of Clinical Pharmacology and Therapeutics, Vol. 51, Núm. 7, pp. 606-614